MARKET

LUNG

LUNG

Pulmonx Corp
NASDAQ
2.301
+0.091
+4.11%
Opening 15:27 01/02 EST
OPEN
2.240
PREV CLOSE
2.210
HIGH
2.339
LOW
2.175
VOLUME
226.03K
TURNOVER
--
52 WEEK HIGH
9.37
52 WEEK LOW
1.310
MARKET CAP
94.91M
P/E (TTM)
-1.6312
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LUNG last week (1222-1226)?
Weekly Report · 12/29/2025 10:28
Weekly Report: what happened at LUNG last week (1215-1219)?
Weekly Report · 12/22/2025 10:28
Analysts Offer Insights on Healthcare Companies: Pulmonx (LUNG), Novan (NOVN) and CVRx (CVRX)
TipRanks · 12/18/2025 17:20
Weekly Report: what happened at LUNG last week (1208-1212)?
Weekly Report · 12/15/2025 10:36
Pulmonx Corporation Files Initial Beneficial Ownership Statement for Chief Science & Technology Officer Srikanth Radhakrishnan
Reuters · 12/11/2025 00:00
Director Daniel P. Florin Reports Sale of Pulmonx Corporation Common Shares
Reuters · 12/09/2025 22:59
Weekly Report: what happened at LUNG last week (1201-1205)?
Weekly Report · 12/08/2025 10:35
Improved Revenues Required Before Pulmonx Corporation (NASDAQ:LUNG) Stock's 26% Jump Looks Justified
Simply Wall St · 12/05/2025 10:09
More
About LUNG
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides minimally invasive treatments for chronic obstructive pulmonary disease (COPD). The Company’s Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System, LungTraX Platform, and StratX Lung Analysis Report are designed to assess and treat patients with severe emphysema/COPD. The LungTraX Platform is a cloud-based quantitative CT (QCT) analysis service that provides physicians with multiple products, LungTraX Connect, to improve workup efficiency, LungTraX Detect, to enable patient identification and an easy-to-read StratX Lung report that it designed for its solution that includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a proprietary balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation.

Webull offers Pulmonx Corp stock information, including NASDAQ: LUNG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUNG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LUNG stock methods without spending real money on the virtual paper trading platform.